Cellebrite DI Ltd
NASDAQ:CLBT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.04
22.52
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cellebrite DI Ltd
Cellebrite DI Ltd
Capital Expenditures
Cellebrite DI Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
Capital Expenditures
-$7.9m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Walkme Ltd
NASDAQ:WKME
|
Capital Expenditures
-$540k
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
Capital Expenditures
-$9.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-1%
|
|
|
N
|
Nice Ltd
TASE:NICE
|
Capital Expenditures
-$95.3m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-18%
|
|
|
H
|
Hilan Ltd
TASE:HLAN
|
Capital Expenditures
-₪87.7m
|
CAGR 3-Years
-95%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-28%
|
|
|
Similarweb Ltd
NYSE:SMWB
|
Capital Expenditures
-$2.4m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cellebrite DI Ltd
Glance View
Cellebrite DI Ltd. has carved a niche for itself in the digital intelligence arena, becoming a beacon for law enforcement and government agencies worldwide. Born in Petah Tikva, Israel, the company began its journey focusing on mobile data transfer technology before pivoting to one of the most critical aspects of modern policing—extracting and analyzing data from digital devices. Cellebrite's flagship product, the Universal Forensic Extraction Device (UFED), allows investigators to retrieve a plethora of data from smartphones, tablets, and other devices. This capability is crucial in solving crimes, making Cellebrite an indispensable partner for agencies tackling everything from cybercrime to terrorism. The company’s business model thrives on providing not just the hardware and software tools but also ongoing support and training services. This creates a steady stream of recurring revenue, as agencies continually rely on Cellebrite for updates in response to the ever-evolving digital landscape. Additionally, their subscription-based offerings grant clients access to the latest forensic advancements, embedding Cellebrite deeper into their operational frameworks. By focusing on combining comprehensive data solutions with robust client support, Cellebrite ensures its position as a leader in the digital intelligence domain, weaving its technology into the very fabric of modern investigative processes.
See Also
What is Cellebrite DI Ltd's Capital Expenditures?
Capital Expenditures
-7.9m
USD
Based on the financial report for Dec 31, 2023, Cellebrite DI Ltd's Capital Expenditures amounts to -7.9m USD.
What is Cellebrite DI Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-9%
Over the last year, the Capital Expenditures growth was 13%. The average annual Capital Expenditures growth rates for Cellebrite DI Ltd have been -9% over the past three years .
You don't have any saved screeners yet
